Media/Newsroom

The Valley Hospital is pleased to be the first hospital in the United States to use Rapiblyk® (landiolol) to treat cardiac arrhythmias among the critically ill patient population. The cardiac critical care team at The Valley Hospital administered the medication as a treatment for atrial fibrillation with a rapid heart rate.

Valley Health System, in partnership with the Icahn School of Medicine at Mount Sinai, is proud to announce the establishment of Graduate Medical Education (GME) fellowship programs to educate and train the next generation of physicians in the specialties of hematology and oncology, cardiovascular disease, and hospice and palliative medicine.

Valley Health System congratulates Robert Brenner, MD, MMM, FACHE, President and Chief Executive Officer of Valley Health System, for being ranked as a healthcare influencer on ROI-NJ’s “ROI Influencers: Power List 2026 – Health Care” list.

The Valley Hospital has once again been awarded Transcatheter Valve Certification from The American College of Cardiology (ACC) for its demonstrated expertise and commitment to treating patients receiving transcatheter valve repair and replacement procedures.

Valley Home Care is pleased to have been recognized for high-performing home healthcare by U.S. News & World Report on the first-ever ratings for Best Home Health. Valley Home Care was 1 of only 8 New Jersey home health agencies to have earned a “high-performing” distinction out of the 43 agencies available in the state. U.S. News & World Report

The Valley Hospital is proud to announce that it has acquired the da Vinci 5 Surgical System, the latest generation in robotic surgical technology.

Valley Medical Group is proud to announce the appointment of Tamar Zapolanski, MD, as Director of Dermatology.

Valley Health System congratulates Robert Brenner, MD, MMM, FACHE, President and Chief Executive Officer of Valley Health System, for his recognition on the 2026 NJBIZ Power 100 list.

Valley Health System is proud to announce that Nick W. Liu, MD, Medical Director of Urology; David T. Ahlborn, MD; and the urologic oncology team have successfully performed Valley’s first prostate cancer procedure using the NanoKnife® System. Valley is the first hospital in Bergen County to use the NanoKnife® System for the treatment of prostate cancer, according to the technology’s manufacturer AngioDynamics.

Valley Health System is proud to offer more appointments with Valley doctors for residents of Montvale and those nearby in a beautiful new building.